EUVIMEDEUVIMED entdecken
Fallbericht

Congenital insensitivity to pain caused by a novel SCN9A genotype

Thorsteinn Bjornsson, Elias Olafsson, Hildigunnur Katrinardottir, Asgeir Sigurdsson, Guðny A Arnadottir, Brynjar Jensson, Asmundur Oddsson, Arnor Vikingsson, Gyda Bjornsdottir, Thorgeir E Thorgeirsson, Patrick Sulem, Olafur Arni Sveinsson

Laeknabladid · 10.06.2026 · 112 (06) · 276-279

DOI: 10.17992/lbl.2026.06.897 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Laeknabladid, online erschienen am 10.06.2026. Verfasst von Thorsteinn Bjornsson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sahlgrenska University Hospital, Gothenburg. Hauptthemen laut MEDLINE: NAV1.7 Voltage-Gated Sodium Channel, Pain Insensitivity, Congenital, Mutation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Congenital insensitivity to pain (CIP) refers to a group of extremely rare genetic disorders characterized by a lifelong inability to sense pain. Interestingly, in most cases, other neurological functions remain essentially intact. Here, we present the long-term follow-up of a 73 year old Icelandic male who, along with his two brothers, were diagnosed with CIP in childhood. This report details his clinical history, neurological findings, and whole genome sequencing results, which confirm and elucidate the genetic basis of his condition, explained by compound heterozygosity of two rare mutations in SCN9A. One has previously been described in CIP (p.Lys1659Ter). The other is a novel CIP variant consisting of a rare deletion (c.417-15_4174-14delAT) that causes exon 23 to be spliced out, and loss of 18 amino acids from the protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.7 Voltage-Gated Sodium ChannelPain Insensitivity, CongenitalMutationHumansMaleGenetic Predisposition to DiseasePhenotypeDNA Mutational AnalysisAgedHeterozygotePedigree

Stichwörter der Autor:innen

long-term follow-upCongenital insensitivity to painSCN9Acase reportnovel compound heterozygous genotype

Substanzen

NAV1.7 Voltage-Gated Sodium ChannelSCN9A protein, human

Autor:innen und Institutionen

  • Department of Neurology, Sahlgrenska University Hospital, Gothenburg.
  • University of Iceland, Faculty of Medicine, 3Department of Neurology, University Hospital of Iceland.
  • Amgen deCODE Genetics (ADG), Reykjavik, Iceland.
  • University of Iceland, Faculty of Medicine.
  • University of Iceland, Faculty of Medicine, Department of Neurology, University Hospital of Iceland.

Zitieren

APA

Bjornsson, T., Olafsson, E., Katrinardottir, H., Sigurdsson, A., Arnadottir, G. A., Jensson, B., Oddsson, A., Vikingsson, A., Bjornsdottir, G., Thorgeirsson, T. E., Sulem, P., & Sveinsson, O. A. (2026). Congenital insensitivity to pain caused by a novel SCN9A genotype. Laeknabladid, 112(06), 276-279. https://doi.org/10.17992/lbl.2026.06.897

Vancouver

Bjornsson T, Olafsson E, Katrinardottir H, Sigurdsson A, Arnadottir GA, Jensson B, et al. Congenital insensitivity to pain caused by a novel SCN9A genotype. Laeknabladid. 2026;112(06):276-279. doi:10.17992/lbl.2026.06.897

BibTeX
@article{Bjornsson2026,
  author = {Bjornsson, Thorsteinn and Olafsson, Elias and Katrinardottir, Hildigunnur and Sigurdsson, Asgeir and Arnadottir, Guðny A and Jensson, Brynjar and Oddsson, Asmundur and Vikingsson, Arnor and Bjornsdottir, Gyda and Thorgeirsson, Thorgeir E and Sulem, Patrick and Sveinsson, Olafur Arni},
  title = {Congenital insensitivity to pain caused by a novel SCN9A genotype},
  journal = {Laeknabladid},
  year = {2026},
  volume = {112},
  number = {06},
  pages = {276--279},
  doi = {10.17992/lbl.2026.06.897}
}
Kostenlos starten →